+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti-Obesity Drugs - Market Analysis, Trends, and Forecasts

  • ID: 834997
  • Report
  • February 2020
  • Region: Global
  • 66 Pages
  • Global Industry Analysts, Inc
1 of 2
Anti-Obesity Drugs market worldwide is projected to grow by US$3.5 Trillion, driven by a compounded growth of 21.2%. Anti-Obesity Drugs, one of the segments analyzed and sized in this study, displays the potential to grow at over 21.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.7 Trillion by the year 2025, Anti-Obesity Drugs will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 23.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$114.5 Billion to the region's size and clout in the next 5 to 6 years. Over US$159.7 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Anti-Obesity Drugs will reach a market size of US$304.8 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.4% over the next couple of years and add approximately US$583.3 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc. (UK)
  • Eisai Co. Ltd. (Japan)
  • Novo Nordisk A/S (Denmark)
  • Rhythm Pharmaceuticals (US)
  • VIVUS Inc. (US)
Note: Product cover images may vary from those shown
2 of 2

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Obesity and Overweight Statistics

Recent Market Activity

Obesity - A Prelude

Anti-Obesity Drugs: A Market Characterized by High Unmet Needs

Currently Available Anti-Obesity Medications

Select Currently Available Short-term and Long-term Anti-Obesity Medication

Select Off-Label Drugs for Obesity

Saxenda Commands the AOM Market, Newer Drugs to Provide Impetus to Market Growth

Semaglutide: Highest Potential in the AOM Pipeline

Setbacks of Past Drugs

Positive Road Ahead for Belviq

Relaunch of Xenical

Relaunch of Contrave®

Reluctance among Patients, Physicians, and Payers Hurts Market Prospects

New Drug Development - High on the Agenda, Despite the Market Restraints

Anti-Obesity Drugs in Phase-III Clinical Trials: As of July 2018

Anti-Obesity Drugs in Phase-II Clinical Trials: As of July 2018

Anti-Obesity Drugs in Phase-I Clinical Trials: As of July 2018

Diabetes Drug Companies Attempt to Foray into the Anti-Obesity Drugs Space

Competitive Landscape

Novo Nordisk - The Leading Player in the Market

The United States - The Largest Obesity and Anti-Obesity Market

Europe - A Market with Vast Potential

Obesity Creeps Up in Developing Countries

Global Competitor Market Shares

Anti-Obesity Drugs Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

F. Hoffmann-La Roche Ltd. (Switzerland)

GlaxoSmithKline Plc. (UK)

Eisai Co., Ltd. (Japan)

Novo Nordisk A/S (Denmark)

Rhythm Pharmaceuticals (USA)

VIVUS, Inc. (USA)

3. MARKET TRENDS & DRIVERS

Alarming Rise in Global Obesity Levels - The Major Growth Factor

Classification of BMI

Rising Incidence of Chronic Diseases Associated with Obesity Drive the Market Expansion

Growing Middle Class Population to Drive the Market Growth

Childhood Obesity - A Market with Unmet Needs

Commercial Weight-Loss Companies Foray into the Market

Online Drug Stores Boost Sales

Barriers to Development of Effective Drugs

Regulatory Additions - A Barrier to Entry?

High Drug Development Costs - A Major Setback

Weight Loss Alternatives - A Market Dampener

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Anti-Obesity Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Anti-Obesity Drugs Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

Market Analytics

TABLE 3: United States Anti-Obesity Drugs Market Estimates and Projections in US$ Million: 2018 to 2025

CANADA

TABLE 4: Canadian Anti-Obesity Drugs Market Estimates and Forecasts in US$ Million: 2018 to 2025

JAPAN

TABLE 5: Japanese Market for Anti-Obesity Drugs: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

CHINA

TABLE 6: Chinese Anti-Obesity Drugs Market Growth Prospects in US$ Million for the Period 2018-2025

EUROPE

Market Facts & Figures

Market Analytics

TABLE 7: European Anti-Obesity Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 8: European Anti-Obesity Drugs Market Share Shift by Region/Country: 2019 VS 2025

FRANCE

TABLE 9: Anti-Obesity Drugs Market in France: Estimates and Projections in US$ Million for the Period 2018-2025

GERMANY

TABLE 10: Anti-Obesity Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

ITALY

TABLE 11: Italian Anti-Obesity Drugs Market Growth Prospects in US$ Million for the Period 2018-2025

UNITED KINGDOM

TABLE 12: United Kingdom Market for Anti-Obesity Drugs: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

REST OF EUROPE

TABLE 13: Rest of Europe Anti-Obesity Drugs Market Estimates and Forecasts in US$ Million: 2018-2025

ASIA-PACIFIC

TABLE 14: Anti-Obesity Drugs Market in Asia-Pacific: Estimates and Projections in US$ Million for the Period 2018-2025

REST OF WORLD

TABLE 15: Rest of World Anti-Obesity Drugs Market Estimates and Forecasts in US$ Million: 2018 to 2025

IV. COMPETITION

Total Companies Profiled: 25

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll